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Tonicity-responsive binding-protein (TonEBP or NFAT5) is a widely expressed transcription factor whose activity is regulated
by extracellular tonicity. TonEBP plays a key role in osmoprotection by binding to osmotic response element/TonE elements
of genes that counteract the deleterious effects of cell shrinkage. Here, we show that in addition to this “classical” stimulation,
TonEBP protects cells against hypertonicity by enhancing nuclear factor-B (NF-B) activity. We show that hypertonicity
enhances NF-B stimulation by lipopolysaccharide but not tumor necrosis factor-, and we demonstrate overlapping protein
kinase B (Akt)-dependent signal transduction pathways elicited by hypertonicity and transforming growth factor-. Activation
of p38 kinase by hypertonicity and downstream activation of Akt play key roles in TonEBP activity, IB degradation, and p65
nuclear translocation. TonEBP affects neither of these latter events and is itself insensitive to NF-B signaling. Rather, we reveal
a tonicity-dependent interaction between TonEBP and p65 and show that NF-B activity is considerably enhanced after
binding of NF-B-TonEBP complexes to B elements of NF-B–responsive genes. We demonstrate the key roles of TonEBP
and Akt in renal collecting duct epithelial cells and in macrophages. These ﬁndings reveal a novel role for TonEBP and Akt
in NF-B activation on the onset of hypertonic challenge.
INTRODUCTION
The nuclear factor-B (NF-B) transcription factor system is
a crucial regulator of numerous physiological processes that
exerts its effects by binding to B sequence elements present
in hundreds of genes involved in inﬂammation, immunity,
cell proliferation, differentiation, and apoptosis. It ensues
that inappropriate activation of NF-B has been linked to
most inﬂammatory diseases (Mattson and Meffert, 2006;
Razani et al., 2008; Simmonds and Foxwell, 2008; Granic et
al., 2009; Rangan et al., 2009; Vallabhapurapu and Karin,
2009). The exact role it plays depends on cell type, the nature
of acting stimuli, and integrative coordination between
NF-B signaling and other signaling pathways. Although
most research has focused on the critical role of NF-Bi n
innate and adaptive immunity, it is now ﬁrmly established
that NF-B plays a pivotal role in the physiology of tissues
outside of the immune system.
Both cell surface receptor-mediated and nonreceptor-me-
diated pathways activate NF-B. Toll-like/interleukin (IL)-1
receptors (TLR/IL-1Rs), nucleotide binding and oligomer-
ization domain-like receptors, and retinoic acid-inducible
gene I-like receptors recognize microbial patterns and acti-
vate NF-B. Members of the tumor necrosis factor (TNF)
receptor (TNFR) family bind TNF, CD40 ligand, lympho-
toxin-1, and B cell-activating factor belonging to the TNF
family, leading to NF-B activation. In addition, activation
of antigen T- and B-cell receptors and other receptors, such
as epidermal growth factor receptor (EGFR) stimulate the
NF-B signaling pathway (Biswas and Iglehart, 2006; Vall-
abhapurapu and Karin, 2009). NF-B inducers that act inde-
pendently of a cell surface receptor include genotoxic stim-
uli such as phorbol esters, UV light, ionizing radiation, and
oxidative stress. Receptor- and nonreceptor-mediated path-
ways typically converge on central components made up of
inhibitor of B( I B) proteins, IB kinases (IKKs), and NF-B
complexes. The major activation pathway by which most
stimuli stimulate NF-B activity is the canonical NF-B sig-
naling pathway (Hayden and Ghosh, 2004; Vallabhapurapu
and Karin, 2009). In this pathway, an active IKK complex,
comprising the catalytic subunits IKK and IKK and the
regulatory subunit IKK (NEMO), phosphorylates IB on
Ser32 and Ser36, leading to its proteasomal degradation.
This exposes a nuclear localization signal present in p65
(RelA), inducing nuclear translocation of the prototypical
NF-B p65/p50 complex. A regulatory feedback loop in-
volving the induction of IB synthesis helps terminate
p65/p50 activation. p65 activity is further regulated by nu-
merous molecules, such as the catalytic subunit of protein
kinase A (PKAc), p38 kinase, and Akt (PKB) that interact
with the NF-B signaling pathway at various stages.
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3459Extracellular osmolality induces a panoply of cellular
changes, affecting various processes such as transporter/
channel activity, transcriptional/translational activity, and
intracellular signaling. Hypertonicity-induced cell shrinkage
exerts harmful effects on cell function that if unchecked lead
to apoptotic cell death. To avoid this, cell volume is imme-
diately restored via a regulatory volume increase (RVI)
mechanism. An adaptation process is subsequently trig-
gered during which intracellular ionic strength is reduced.
This involves increased signaling of various osmoprotective
responses in which both mitogen-activated protein, kinases
and phosphatidylinositol 3-kinase (PI3-kinase) play key
roles (Nahm et al., 2002; Sheikh-Hamad and Gustin, 2004).
Tonicity-responsive enhancer binding-protein (TonEBP or
NFAT5), which belongs to the Rel/NFAT family of tran-
scription factors, plays a critical role in RVI by controlling
the expression of osmoprotective genes including heat-
shock protein 70 and genes that mediate the intracellular
accumulation of small organic osmolytes that reduce intra-
cellular ionic strength without affecting protein function,
such as aldose reductase (AR), sodium-chloride-betaine co-
transporter (BGT1), and sodium-myo-inositol cotransporter
(SMIT) (Burg et al., 2007; Kwon et al., 2009).
Numerous cell types throughout the body are exposed to
aniosmotic environments. Environmental osmolality is
greatest in the kidney where levels as high as 1200
mOsmol/kg can be reached at the tip of the inner medulla in
humans. Hypertonicity was shown to increase NF-B activ-
ity in both renal medullary interstitial cells and collecting
duct principal cells (Hao et al., 2000; Hasler et al., 2008). In
the latter study, we showed that increased NF-B activity by
hypertonicity relies on IKK,I B, and p65 activity. In the
present study, we aimed at identifying additional intracel-
lular components mediating NF-B activation by hyperto-
nicity in collecting duct principal cells and macrophages. We
show that increased NF-B activity by hypertonicity relies
on an Akt-mediated increase of IB degradation, increased
p65 nuclear translocation, an interaction between p65 and
TonEBP, and binding of p65-TonEBP complexes to B ele-
ments of NF-B–responsive genes.
MATERIALS AND METHODS
Cell Culture and Transfection
mCCDcl1 and HepG2 cells were cultured as described previously (Gaeggeler
et al., 2005; Vinciguerra et al., 2009) and mpkCCDcl4 cells (passages 28–34)
were seeded on permeable ﬁlters (Transwell; Corning Life Sciences, Lowell,
MA) as described previously (Hasler et al., 2005). For nuclear extract prepa-
rations and immunoprecipitation and chromatin immunoprecipitation (ChIP)
assays requiring large quantities of protein, cells were grown on T-75 ﬂasks
(Corning Life Sciences). Cells were grown to conﬂuence and then in serum-
and hormone-free medium for 24 h before performing experiments. H36.12j
cells are mouse hybrid precursor macrophages (Canono and Campbell, 1992)
that adhere poorly to plastic supports. Cells (5  105/well) were added to 12
well plates and grown in suspension in Dulbecco’s Modiﬁed Eagle’s Medium
containing 580 mg/l glutamine (Invitrogen, Carlsbad, CA) and supplemented
with 10% fetal calf serum, penicillin G sodium (10,000 U/ml), and strepto-
mycin sulfate (10,000 mg/ml) (Invitrogen). Cells were grown at 37°C in a
humidiﬁed atmosphere containing 5% CO2 for 2 d and then exposed over-
night to serum- and hormone-free medium before performing experiments.
For all cells, iso-osmotic medium (300 mOsmol/kg) was made hypertonic
(350–600 mOsmol/kg) by replacing a fraction of the medium (apical and
basal for mCCDcl1 and mpkCCDcl4 cells grown on ﬁlters) with NaCl-enriched
(1100 mOsmol/kg) medium. Medium osmolality was checked using an os-
mometer. Contrary to lipopolysaccharide (LPS), TNF- and transforming
growth factor (TGF)- only increased NF-B activity when applied to the
basal medium of cells grown on ﬁlters. For this reason, NF-B stimulation was
limited to LPS and hypertonicity for experiments performed on mpkCCDcl4
cells grown on T-75 ﬂasks.
Transfection was performed as described previously (Mordasini et al., 2005)
by electroporating cells in the presence of either 1.2 nmol of Stealth RNAi
small interfering RNA (siRNA) (Invitrogen; Table 1), 8 pmol of plasmid
containing either eGFP, human TonEBP (Maouyo et al., 2002), constitutively
active IKK (Mercurio et al., 1997), or super-repressor IB (Oyama et al.,
1998) mutants, or 8 pmol of plasmid containing luciferase constructs. We have
estimated previously that 70% of mpkCCDcl4 cells are efﬁciently transfected
by electroporation (Hasler et al., 2006a). Transfected cells were grown in
culture medium supplemented with 10% fetal calf serum for 24 h (6 h for cells
transfected with RNA interference [RNAi]) and then in serum- and hormone-
free medium for 24 h before performing experiments.
Real-Time Polymerase Chain Reaction (PCR) Analysis
Total mRNA was isolated using the NucleoSpin RNA II kit according to the
manufacturer’s instructions (Machery Nagel, Du ¨ren, Germany). Reverse tran-
scription and real-time PCR analysis were performed as described previously
(Hasler et al., 2005). Primer sequences used for real-time PCR analysis are
shown in Table 2. Mouse acidic ribosomal phosphoprotein (P0) was used as
an internal standard, and data were analyzed as described previously (Hasler
et al., 2006b). None of the stimuli, pharmacological compounds, or RNAi was
found to signiﬁcantly alter P0 expression, as exempliﬁed in Supplemental
Figure S1. Quantitative PCR was performed in triplicate.
Western Blot Analysis
Preparation of cell lysates was performed as described previously (Hasler et
al., 2005), and equal amounts of protein (10 g) were separated by NuPage
4–12% BisTris gel (Invitrogen) electrophoresis. Bands were quantiﬁed using
Photoshop (Adobe Systems, Mountain View, CA). Experiments were re-
peated at least three times with consistent results. Antibodies are shown in
Table 3.
Luciferase Assay
Cells were transfected with either a TonE-driven luciferase plasmid p(kB)3
IFN-Luc containing three copies of TonE upstream of SV40 promoter and
luciferase (Miyakawa et al., 1998) or a B-driven luciferase plasmid containing
three tandemly repeated B motifs upstream of a minimal interferon (IFN)-
promoter (55 to  19) and luciferase (Fujita et al., 1993). Luciferase activity
after 12 h of stimulation was measured using the Luciferase Assay System
(Promega, Madison, WI) according to the manufacturer’s instructions. The
light produced was measured using a Lumat LB 9507 luminometer (Berthold
Technologies, Bad Wildbad, Germany).
Immunoprecipitation
Cells grown on T-75 ﬂasks were lysed in homogenizing buffer (HB: 2 mM
EDTA, 2 mM EGTA, 40 g/ml leupeptin, 2 g/ml aprotinin, 30 mM NaF, 30
mM Na pyrophopshate, 1 mM phenylmethylsulfonyl ﬂuoride, 1 mM AEBSF,
20 mM Tris-HCl, pH 7.4, 2 mM sodium orthovanadate, and 0.5% saponin).
Protein (500 g–1 mg) was incubated overnight at 4°C with 10 l of rabbit
anti-TonEBP immunoglobulin (Ig)G, mouse anti-p65 IgG, or rabbit anti-Na,K-
ATPase  subunit IgG. After1ho fincubation with protein A-Sepharose
beads, ﬁve washing steps were performed in HB. Precipitated proteins were
separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE) and p65 or
TonEBP was revealed by Western blotting.
Preparation of Nuclear and Cytosolic Extracts
Cells were scrapped off, spun at 1500  g, and homogenized in lysis buffer A
(10 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM [4-(2-
aminoethyl)benzenesulfonylﬂuoride], 10 g/ml leupeptin, and 4 g/ml
aprotinin) on ice for 10 min. The cell extract was then spun at 13,000  g, and
the supernatant, corresponding to cytosolic extract, was collected. The pellet
was resuspended in the same lysis buffer and respun. The pellet was then
resuspended in lysis buffer B (20 mM HEPES-KOH, pH 7.9, 25% glycerol, 420
mM NaCl, 1.5 mM MgCl2, 0.2 M EDTA, 1 mM [4-(2-aminoethyl)benzenesul-
fonylﬂuoride], 10 g/ml leupeptin, and 4 g/ml aprotinin) on ice for 40 min
and spun at 18,000  g. The supernatant, corresponding to nuclear extract,
was then collected. Cytosolic and nuclear extract (1 g) was loaded on gels for
Western blotting analysis.
Table 1. RNAi target sequence
Targeted gene RNAi sense primer
c-Jun GAGAGCGGUGCCUACGGCUACAGUA
p38 kinase  CCGACGACCACGTTCAGTTTCTCAT
MyD88 CCAUUGCCAGCGAGCUAAUUGAGAA
TNFR1 CCCAAGGAAAGUAUGUCCAUUCUAA
TNFR2 CCUGGCCAAUAUGUGAAACAUUUCU
TonEBP CCUAGUUCUCAAGAUCAGCAAGUAA
Scrambled TonEBP CCUCUUACUAGAACUACGGAAGUAA
I. Roth et al.
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ChIP was performed as described previously (Hasler et al., 2008) by using
antibodies against p65 and TonEBP (Table 3). Real-Time PCR of immunoprecipi-
tated DNA fragments was performed as described above using primers shown in
Table 2.
DNA Afﬁnity Puriﬁcation Analysis (DAPA)
Nuclear extracts obtained as described above were subjected to DAPA as
described previously (Deng et al., 2003). DNA probes (15 nM) biotinylated on
5 ends (Microsynth, Balgach, Switzerland) and encoding B sites of mouse
TNF- and MCP-1 promoters were mixed with 200 g of nuclear extract, 50
l of streptavidin-coated agarose beads, and protease inhibitors (Roche Ap-
plied Science, Penzberg, Germany). The sequence of the primer against mouse
TNF- was 5-AAGAACTCAAACAGGGGGCTTTCCCTCCTCAATATCAT
and that against monocyte chemoattractant protein (MCP)-1 was 5-GGTCT-
GGGAACTTCCAATACTGCCTCAGAATGGGAATTTCCACGCTCT. The ﬁ-
nal volume was adjusted to 500 l with nuclear lysis buffer B and incubated
at room temperature for 1 h with end-over-end rotation. Beads were pelleted,
washed four times with ice-cold phospate-buffered saline, and then resus-
pended in 50 l of Laemmli sample buffer. Precipitated proteins were sepa-
rated by 10% SDS-PAGE and identiﬁed by Western blot analysis using
antibodies against TonEBP and p65 (Table 3).
Statistics
Results are given as the mean  SE from n independent experiments. Each
experiment was performed on cells from the same passage. All experiments
were performed at least three times. Statistical differences were assessed using
the student’s t test (*p  0.05). No statistical differences between experimental
points are depicted as NS.
RESULTS
Hypertonicity Increases NF-B Activity in a p38
Kinase-dependent Manner
We demonstrated previously (Hasler et al., 2008) a transient
increase of NF-B activity occurring in mpkCCDcl4 cells
Table 2. Real-time PCR primer sequences
Targeted gene Forward Reverse
P0 AATCTCCAGAGGCACCATTG GTTCAGCATGTTCAGCAGTG
TNF GACCCTCACACTCAGATCATCTTCT CCACTTGGTGGTTTGCTACGA
MCP-1 GGCTCAGCCAGATGCAGTTAA CCTACTCATTGGGATCATCTTGCT
IB CGGAGGACGGAGACTCGTT TTCACCTGACCAATGACTTCCA
p38 kinase  CCTTGCCACTTTGGCTTCTC AGCAGCCTCTCTCTGTCACTGA
c-Jun GCAGAGAGGAAGCGCATGA CCTTTTCCGGCACTTGGA
AR AGTGCGCATTGCTGAGAACTT GTAGCTGAGTAGAGTGGCCATGTC
BGT1 CTGGGAGAGACGGGTTTTGGGTATTACATC GGACCCCAGGTCGTGGAT
SMIT CCGGGCGCTCTATGACCTGGG CAAACAGAGAGGCACCAATCG
MyD88 GCTCAACCCGTGTTCAATGA GGTGGCTGGGAGGAAAGG
TNFR1 TCCGCTTGCAAATGTCACA GGCAACAGCACCGCAGTAC
TNFR2 CTTGCGAAGCTGGCAGGTA TGTCGACAGCTGCCAGAATG
ChIP
TNF CCCAACTCTCAAGCTGCTCT CTTCTGAAAGCTGGGTGCAT
MCP-1 ATCTGGAGCTCACATTCCA TCCCTCTCACTTCACTCTGTCA
B GCTTCTCAGTGGAGGACGAG CTGGCTGAAACATGGCTGT
AR CCAGTCGGTGCCCTCT TTAGAGAAAAAGTACACCAGAATTTCC
Table 3. Antibodies
Host Dilution Manufacturer
Primary antibodies
p38 kinase Rabbit 1:1000 Cell Signaling Technology, Danvers, MA
Phospho-p38 kinase Rabbit 1:2500 Cell Signaling Technology
Phospho-ATF2 Rabbit 1:2000 Cell Signaling Technology
Erk2 Rabbit 1:1000 Santa Cruz Biotechnology, Santa Cruz, CA
Phospho-ERK1/2 Rabbit 1:2000 Cell Signaling Biotechnology
JNK1 Rabbit 1:1000 Santa Cruz Biotechnology
JNK2 Rabbit 1:1000 Santa Cruz Biotechnology
Phospho-JNK1/2 Mouse 1:1000 Santa Cruz Biotechnology
c-Jun Rabbit 1:2000 Cell Signaling Technology
Phospho-c-jun Mouse 1:1000 Santa Cruz Biotechnology
Akt Rabbit 1:2500 Santa Cruz Biotechnology
Phospho-Akt (S473) Rabbit 1:2500 Cell Signaling Technology
p50 Mouse 1:500 Santa Cruz Biotechnology
p65 Mouse 1:1000 Santa Cruz Biotechnology
IB Rabbit 1:2500 Santa Cruz Biotechnology
HDAC3 Rabbit 1:1000 Cell Signaling Technology
Tubulin Mouse 1:10000 Sigma Aldrich, St. Louis, MO
Na,K-ATPase  subunit Rabbit 1:1000 Carranza et al. (1996)
PKAc Rabbit 1:2500 Santa Cruz Biotechnology
TonEBP Rabbit 1:2000 Miyakawa et al. 1999
Secondary antibodies
Horseradish peroxidase (HRP)-conjugated anti-rabbit Goat 1:20000 BD Biosciences, San Jose, CA
HRP-conjugated anti-mouse Goat 1:20000 BD Biosciences
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urea-hyperosmotic medium (500 mOsmol/kg). In that
study, NF-B activity increased after2ho fhypertonic chal-
lenge and returned toward baseline levels 24 h later. More
recently, as revealed by increased levels of TNF- mRNA
expression, we reproduced the enhancer effect of hyperto-
nicity in another cortical collecting duct cell line, mCCDcl1,
and in nonrenal cell lines, such as hepatocytes and macro-
phages. In these cells, NF-B activity increased 2- to 5-fold
after3ho fhypertonic challenge (500 mOsmol/kg). The
most robust response, however, corresponding to a 40-fold
increase of TNF- mRNA expression, was achieved in mp-
kCCDcl4 cells. For this reason, we used this cell line to
investigate intracellular events that mediate increased
NF-B activity on the onset of NaCl-hypertonic challenge.
We sought to gain further insight on hypertonicity-inducible
events affecting NF-B signaling by comparing hypertonic
effects with those elicited by TLR/IL-1R or TNFR activation.
A comparison of mRNA expression levels between three
NF-B–dependent genes (TNF-, MCP-1, and IB) re-
vealed varying extents of NF-B activation achieved by hy-
pertonic, LPS, or TNF- challenge (Figure 1). NF-B activa-
tion was highest in cells challenged 3 h with 10 ng/ml LPS
(Figure 1, A–C). These levels were at least twice as high as
those achieved by 10 ng/ml TNF- (Figure 1, E–G) and
approximately 4 times as high as those induced by 500
mOsmol/kg hypertonic medium (Figure 1, I–K). Time-
course experiments performed on all three NF-B-depen-
dent genes further revealed that the stimulatory effect of LPS
and TNF- was sustained for longer periods compared with
that produced by hypertonicity (compare Figure 1, D and H,
to L). In view of these results, unless explicitly stated, we
used 10 ng/ml LPS, 10 ng/ml TNF-, and 500 mOsmol/kg
NaCl-hypertonic medium for 3 h for all experiments in this
study.
Activation of MAP kinase (MAPK) pathways is a hall-
mark of the hypertonic response. Phosphorylation of p38
kinase, p38 kinase substrate ATF2, extracellular signal-reg-
ulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and
JNK substrate c-Jun was especially high after 30 min of
hypertonic but not LPS or TNF- challenge (Figure 2, A and
C), returning toward baseline levels after3ho fchallenge
(data not shown). Total MAPK protein expression was not
altered by any stimulus (data not shown). To investigate the
Figure 1. Hypertonicity increases NF-B activity in mpkCCDcl4 cells. Real-time PCR analysis of TNF- (A, E, and I), MCP-1 (B, F, and J),
and IB (C, G, and K) transcripts in mpkCCDcl4 cells after3ho fL P S( 1pg/ml–100 ng/ml), TNF- (1 pg/ml–100 ng/ml), or NaCl-hypertonic
challenge (350–600 mOsmol/kg). Data are normalized to acidic ribosomal phosphoprotein P0 and is represented as fold induction over
nonstimulated (Ctl) cells. Also shown are time course expression analysis of each transcript by LPS (10 ng/ml; D), TNF- (10 ng/ml; H), and
NaCl hypertonic challenge (500 mOsmol/kg; L).
I. Roth et al.
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ible NF-B activation, we measured the effects of pharma-
cological inhibition of p38 kinase, ERK, and JNK. A compar-
ison of ATF2 (used as an indicator for p38 kinase activity),
ERK and c-Jun (used as an indicator for JNK activity) phos-
phorylation revealed that each inhibitor (10 M SB203580
against p38 kinase, 10 M U0126 against mitogen-activated
protein kinase kinase [MEK], and 10 M SP600125 against
JNK) decreased its targeted protein activity but not the
activities of the other two kinases, in response to 30 min of
hypertonic challenge (Figure 2, B and C). Pharmacological
inhibition of either p38 kinase, ERK, or JNK activity de-
creased NF-B activity induced by3ho fL P So rTNF-
challenge, as suggested by decreased TNF- mRNA expres-
sion (Figure 2, D and E, left). Pharmacological inhibition of
p38 kinase, but not ERK, activity, greatly reduced TNF-
transcript accumulation after3ho fhypertonic challenge.
RNAi against p38 kinase mimicked the attenuating effect of
SB203580 on increased TNF- mRNA expression by either
LPS, TNF-, or hypertonic challenge, although the inhibi-
tory effect was smaller (Figure 2D, right). Altered MCP-1
and IB mRNA expression in response to pharmacological
MAP kinase inhibition is shown in Supplemental Figure S3.
Notably, although SB203580 blunted the hypertonicity-in-
duced increase of MCP-1 mRNA expression, IB mRNA
expression was unchanged. Unexpectedly, the stimulatory
effect of hypertonicity was enhanced by JNK inhibition (Fig-
ure 2C). We further investigated this effect by RNAi knock-
down against c-Jun. c-Jun protein expression increased in
response to3ho fhypertonic challenge, whereas RNAi
efﬁciently decreased expression of both total and phosphor-
ylated pools of c-Jun (Figure 2C). The effects of RNAi c-Jun
knockdown on inducible TNF- mRNA expression echoed
those obtained by pharmacological JNK inhibition, i.e., a
Figure 2. NF-B activation by hypertonicity in part depends on p38 kinase
activity. (A) Protein lysates from cells challenged or not (Ctl) with either LPS,
TNF-, or hypertonic medium (NaCl) were analyzed by immunoblot for
phosphorylated forms of p38 kinase, p38 substrate ATF2, ERK, JNK, and JNK
substrate c-Jun. PKAc was used as a loading control. (B) Protein lysates from
cells pretreated or not for 30 min with 10 M SB203580 (a p38 kinase inhibitor),
10 M U0126 (a MEK inhibitor), or 10 M SP600125 (a JNK inhibitor) and then
challenged or not (Ctl) with hypertonic medium were analyzed by immunoblot
for phosphorylated forms of ATF2, ERK, and c-Jun. (C) Fold protein phosphorylation following hypertonic challenge over baseline levels (Ctl)
is shown at left. Fold decrease of protein phosphorylation by pharmacological inhibitors in hypertonicity-challenged cells is shown at right.
(D and E) Real-time PCR analysis of TNF- transcript after LPS, TNF-, or hypertonic challenge in the presence or absence of either SB203580
or U0126 (D, left) or SP600125 (E; left). (D and E) Right, effects of SB203580 and SP600125 on TNF- transcript expression were echoed by
RNAi against p38 (D) or c-Jun (E), respectively. Immunoblots depicting decreased expression levels of target protein by RNAi are also
shown. PKAc was used as a loading control. (F) Left, real-time PCR analysis of AR, BGT1, and SMIT transcripts in cells treated or not with
a pharmacological inhibitor and challenged or not (Ctl) with hypertonic medium. Data are represented as fold induction over nonstimulated
cells in the absence of an inhibitor. Similar to SB203580, RNAi against p38 reduced the enhancer effect of hypertonicity on AR, BGT1, and
SMIT transcript expression (right). The effects of pharmacological compounds and RNAi on basal mRNA expression levels for this and all
other ﬁgures are shown in Supplemental Figure S2.
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inducibility by hypertonicity. Increased TNF- expression
in response to c-Jun knockdown was moreover found to
occur despite decreased p38 kinase phosphorylation (Fig-
ure 2C). These results suggest that NF-B activation by
hypertonicity is repressed by JNK but partly depends on
p38 kinase activity. We focused our investigations on this
latter dependence.
TonEBP Mediates Increased NF-B Activity by
Hypertonicity
TonEBP is a major transcription factor whose activity is
regulated by extracellular tonicity. Results of previous stud-
ies provide evidence that p38 kinase signaling contributes to
TonEBP activity (Nadkarni et al., 1999; Ko et al., 2002; Irar-
razabal et al., 2008; Kuper et al., 2009). In this study, with the
exception of a small but signiﬁcant decrease of SMIT mRNA
expression by U0126, we found that inhibition of p38 kinase
activity by SB203580, but not ERK or JNK activity by their
respective pharmacological inhibitors, decreased TonEBP
activity under hypertonic conditions, as revealed by reduced
levels of AR, BGT1, and SMIT mRNA expression (Figure 2F,
left). It should be noted that TonEBP activity was previously
found to be enhanced by p38 but inhibited by p38 (Zhou
et al., 2008). Because the activities of both p38 isoforms are
increased by hypertonicity (Zhou et al., 2008), it is possible
that their opposing effects may negate any effect on TonEBP
activity. SB203580 inhibits p38 but not p38 activity (Gum
et al., 1998). Regardless of whether decreased TonEBP activ-
ity shown in Figure 2D arises from decreased p38 activity
or unmasked p38 activity, these data suggest that p38
kinase helps modulate TonEBP activity. This is supported by
the observation that increased AR, BGT1, and SMIT mRNA
expression by hypertonicity was slightly but signiﬁcantly
reduced in cells transfected with RNAi against p38 kinase
(Figure 2F, right). These observations led us to investigate a
possible role for TonEBP in hypertonicity-induced NF-B
activation. We proceeded by comparing the effects of 3 h
hypertonic challenge (400 and 500 mOsmol/kg) in cells
transfected with cDNA encoding TonEBP that express high
levels of TonEBP protein (Figure 3A) and cells transfected
with RNAi against TonEBP that express low levels of
TonEBP protein (Figure 3E). TonEBP activity in response to
hypertonicity was enhanced in cells expressing high levels
of TonEBP protein, as demonstrated by a 50% increase of
TonEBP-dependent luciferase activity and a 50% and seven-
fold increase of AR and BGT1 mRNA expression, respec-
tively, compared with cells transfected with cDNA encoding
enhanced green ﬂuorescent protein (eGFP; data not shown).
We demonstrated previously strong down-regulation of
TonEBP activity by TonEBP RNAi (Hasler et al., 2006a).
High levels of TonEBP expression enhanced NF-B acti-
vation by hypertonicity, as demonstrated by increased
TNF-, MCP-1, and IB mRNA expression (Figure 3, B–D).
Inversely, low levels of TonEBP expression reduced NF-B
activation by hypertonicity, as shown by decreased TNF-,
MCP-1, and IB mRNA expression (Figure 3, F–H). These
results show that the stimulatory effect of hypertonicity on
NF-B activity depends at least in part on TonEBP activity.
Conversely, NF-B activation by LPS or TNF- was only
marginally affected by changes in TonEBP expression (Fig-
ure 3), indicating that the inﬂuence of TonEBP on NF-B
activity is predominately governed by increased TonEBP
activity by hypertonic challenge. We next investigated
whether “classical” NF-B stimuli affect TonEBP activity.
Neither LPS nor TNF- affected TonEBP-dependent gene
transcription (Figure 4A). LPS had no effect on TonEBP-
induced luciferase activity, even in cells overexpressing
TonEBP (Figure 4B). We demonstrated previously the en-
hancing and repressive effects of constitutively active IKK
and super repressor IB mutants on NF-B activity in
transfected mpkCCDcl4 cells (Vinciguerra et al., 2005; Leroy
et al., 2007; Hasler et al., 2008). We show here that TonEBP-
dependent gene transcription is not affected by either mu-
tant under either isotonic or hypertonic conditions (Figure
4C), providing additional evidence that TonEBP is not sen-
sitive to stimuli that increase canonical NF-B signaling.
Together, these results show that TonEBP activity is not
inﬂuenced by canonical NF-B signaling and that although
it plays a key role in mediating NF-B activation by hyper-
tonicity, its role in mediating LPS or TNF- signaling is less
obvious.
Increased NF-B Activity by Hypertonicity Relies on Akt
Kinase Signaling
TonEBP has been shown previously to bind to a TonE ele-
ment present in the TNF- promoter (Lopez-Rodriguez et
al., 2001; Esensten et al., 2005; Lee et al., 2008; Hao et al., 2009)
and such elements might be present in the promoters of
other NF-B–sensitive genes, including MCP-1 and IB as
well. However, we demonstrated previously that super re-
pressor IB mutant and RNAi against p65 signiﬁcantly
reduce NF-B activation by hypertonicity (Hasler et al.,
2008). TonEBP activity is not affected by canonical NF-B
signaling (Figure 4), strongly suggesting that controlled
gene transcription by TonEBP is mediated both by its inter-
action with TonE elements of NF-B–sensitive genes, if
present, and additionally by its interaction with elements of
the NF-B pathway. Our next aim was to identify hyperto-
nicity-inducible elements that participate in IKK activation.
We proceeded by comparing the effects of hypertonicity to
those induced by LPS and TNF-. A summary of the tools
used for this study is shown in Figure 5A. Data suggesting
that hypertonicity stimulates EGFR (Rosette and Karin,
1996) and that active EGFR stimulates both NF-B (Sun and
Carpenter, 1998; Sethi et al., 2007) and TonEBP (Kuper et al.,
2009) led us to additionally compare the effects of hyperto-
nicity to those induced by active EGFR. Numerous mole-
cules bind to EGFR eliciting its activation. In particular,
TGF- was proposed to contribute to TonEBP activation by
hypertonicity (Kuper et al., 2009). For this reason, we used
TGF- as an EGFR agonist. Using an antibody neutralization
approach, we ﬁrst show that NF-B activation by hyperto-
nicity does not arise from autocrine secretion of either
TNF- or TGF- (Figure 5, B and C). Indeed, although
antibodies against either TNF- or TGF- effectively
quenched ligand ability to induce NF-B activity in a dose-
dependent manner, they did not affect NF-B activation by
hypertonicity. Of course, we cannot rule out the possibility
that secretion of other molecules may initiate hypertonic
signaling. We next investigated whether NF-B activation
by LPS, TNF-, or TGF- is affected by hypertonicity. Al-
though TNF- mRNA expression by LPS was enhanced by
either TNF- or hypertonic challenge, that elicited by TNF-
(100 ng/ml) was not affected by hypertonicity (Figure 5D).
In addition, although TGF- increased the effects of both
TNF- and LPS, it did not affect the hypertonic response
(Figure 5D). Supplemental Figure S4A shows that changes in
TNF- mRNA expression were echoed by changes in MCP-1
and IB mRNA expression. We examined the effects of
down-regulated TLR/IL-1R, TNFR, and EGFR activity on
NF-B activation by hypertonicity by using RNAi against
MyD88, RNAi against TNFR1 and TNFR2, and the EGFR
antagonist AG1478 (10 M), respectively (Figure 5E). RNAi
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(by 86  1%) and reduced LPS-induced NF-B activity to a
much greater extent than that induced by TNF-. RNAi
against TNFR reduced target mRNA expression (by 90  1
and 46  4% for TNFR1 and TNFR2, respectively) and
reduced TNF- but not LPS signaling. Importantly, as indi-
cated by changes in TNF- mRNA expression, and also by
similar changes in MCP-1 and IB mRNA expression (Sup-
plemental Figure S4B), NF-B activation by hypertonicity
was not affected by down-regulated signaling of either TLR/
IL-1R or TNFR. Decreased EGFR signaling by AG1478, in
contrast, reduced not only the effects of TGF- but also those
elicited by LPS, TNF-, and hypertonicity. Supplemental
Figure S4 shows that although changes in MCP-1 mRNA
expression echoed those observed for TNF- mRNA, IB
mRNA expression was insensitive to both TFG stimulation
and AG1478. Together, these results are indicative of com-
mon intracellular elements between hypertonicity and
TGF- and TNF-, but not LPS, signaling pathways.
Akt is a major target of EGFR (Citri and Yarden, 2006). We
examined a putative role for Akt in hypertonicity-induced
NF-B signaling by measuring the effects of pharmacologi-
cal inhibition of PI3-kinase and its downstream target Akt
(Figure 6). Increased Akt phosphorylation after 30 min of
TGF- or hypertonic stimulation, but not LPS or TNF-
stimulation, was efﬁciently reduced by 30-min preincuba-
tion in the presence of either wortmannin (100 nM), a PI3-
kinase inhibitor, or triciribine (30 M), an inhibitor of Akt
(Figure 6, A and B). Interestingly, decreased Akt phosphor-
ylation by either pharmacological agent did not inﬂuence
p38 kinase phosphorylation by hypertonicity, whereas
SB203580 abolished Akt phosphorylation by hypertonicity
but not by TGF- (Figure 6, A and B). Similar results were
obtained using another p38 kinase inhibitor (SB202190; data
not shown). These results indicate that p38 kinase at least
partly mediates increased Akt kinase activity by hypertonic-
ity. TGF- challenge alone, which does not induce p38 ki-
nase phosphorylation, failed to elicit TonEBP-dependent
Figure 3. TonEBP mediates NF-B activation by hypertonicity. (A and E) Immunoblot of protein lysates from cells transfected with cDNA
encoding eGFP or TonEBP (A) or transfected with scrambled RNAi or RNAi against TonEBP (E). The arrow in A depicts the band
corresponding to TonEBP. In E, PKAc was used as a loading control. (B–D and F–H) real-time PCR analysis of TNF-, MCP-1, and IB
transcripts in cells transfected with cDNA encoding eGFP or TonEBP (B–D) or transfected with scrambled RNAi or RNAi against TonEBP
(F–H) and challenged or not (Ctl) with hypertonic medium (400 or 500 mOsmol/kg), LPS, or TNF-. Data are represented as fold induction
over nonstimulated cells transfected with eGFP or scrambled RNAi.
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normal levels of p38 kinase phosphorylation, AG1478, wort-
mannin, and triciribine all reduced TonEBP-dependent gene
transcription in response to hypertonicity and TonEBP ac-
tivity was most efﬁciently reduced by simultaneous inhibi-
tion of p38 kinase and Akt activity (Figure 6D). These results
indicate that increased TonEBP activity by hypertonicity is
mediated by both p38 kinase and Akt. Reﬂecting reduced
TonEBP activity, inhibition of PI3-kinase and Akt activity
reduced TNF- mRNA expression by hypertonicity as well,
with maximal reduction after simultaneous inhibition of
both p38 kinase and Akt activity (Figure 6C). Supplemental
Figure S5 shows that although changes in MCP-1 mRNA
expression echoed those of TNF- mRNA, neither wortman-
nin nor triciribine decreased hypertonicity-induced IB
mRNA expression. Together, these results demonstrate that
activation of TonEBP and NF-B by hypertonicity depends
on increased activity of both p38 kinase and Akt.
Hypertonicity Induces Akt-dependent, but
TonEBP-independent, IB Degradation and p65
Nuclear Translocation and Induces Interactivity between
p65 and TonEBP
Super-repressor IB effectively blunts increased NF-B ac-
tivity by hypertonicity (Hasler et al., 2008). This incited us to
compare IB degradation by hypertonicity to that induced
by LPS, TNF-, or TGF- (Figure 7A). Although all four
stimuli elicited IB degradation, each stimulus produced a
different time-dependent degradation signature. LPS-in-
duced IB degradation greatly varied over time, whereas
that induced by TGF- gradually increased to reach maxi-
mal levels after1ho fstimulation after which IB expres-
sion increased. TNF- and hypertonicity produced similar
degradation patterns, although IB degradation in re-
sponse to TNF- was greater than that after hypertonic
challenge. Interestingly, hypertonicity was the only stimulus
observed to increase IB expression, an event that was
already induced after1ho fstimulation. IB degradation at
the onset of hypertonic challenge is most likely supplanted
by the combined effects of novel IB protein synthesis and
the stabilizing effect of hypertonicity, but not LPS or TNF-,
on IB mRNA (Figure 7B).
In addition to inducing IB degradation, hypertonic
challenge instigated redistribution of p65 from a cytoplas-
mic pool to a nuclear pool (Figure 7C). This contrasts with
previous observations by immunoﬂuorescence microscopy
that found no effect of hypertonicity on p65 subcellular
localization (Lopez-Rodriguez et al., 2001). Our immunoﬂu-
orescence microscopy analysis of mpkCCDcl4 cells revealed
that although LPS increased p65 nuclear translocation, the
effect produced by hypertonicity was less obvious (data not
shown). In view of these results, we believe that Western
blotting of cytoplasmic and nuclear protein extracts is more
appropriate in detecting small changes of p65 distribution
between nuclear and cytosolic compartments. As expected
from previous observations (Figure 4), hypertonicity in-
creased TonEBP nuclear localization, whereas LPS had no
effect. We investigated a putative role of TonEBP in the
hypertonicity-induced increase of IB degradation/p65
nuclear import. Although pharmacological inhibition of Akt
blunted IB degradation by hypertonicity (Figure 7D),
RNAi against TonEBP did not affect the alterations of IB
expression that follow hypertonic challenge (Figure 7E).
Similarly, reduced TonEBP expression had no effect on p65
nuclear translocation after 30 min of hypertonic challenge
(Figure 7F). Together, these data indicate that TonEBP does
not inﬂuence either IB degradation or nuclear transloca-
tion of p65-containing NF-B complexes on the onset of
hypertonic challenge.
We next investigated whether TonEBP associates with
p65. Antibodies against p65 and TonEBP were found to
coimmunoprecipitate TonEBP and p65, respectively, under
Figure 4. IKK and IB do not inﬂuence
TonEBP activity. (A) Real-time PCR analysis of
AR, BGT1, and SMIT transcripts in cells chal-
lenged with LPS or TNF-. Data are repre-
sented as fold expression over nonstimulated
(Ctl) cells. (B) TonEBP-driven luciferase activ-
ity in response to hypertonic (NaCl) or LPS
challenge. Cells were transfected with p(kB)3
IFN-Luc plasmid and cotransfected with
cDNA encoding either eGFP or TonEBP. Data
shown is represented as fold induction over
nonstimulated cells transfected with cDNA en-
coding eGFP. (C) Real-time PCR analysis of
AR and SMIT transcripts in cells transfected
with cDNA encoding eGFP or constitutively
active IKK or IB and challenged or not
(Ctl) with hypertonic medium. Data shown is
represented as fold induction over nonstimu-
lated cells transfected with cDNA encoding
eGFP.
I. Roth et al.
Molecular Biology of the Cell 3466hypertonic conditions (Figure 8A). Although visible under
isotonic conditions, the intensity of immunoprecipitated
bands increased along with the duration of hypertonic chal-
lenge (10 vs. 30 min of challenge). Luciferase activity, driven
by a promoter containing B but not TonE motifs (Fujita et
al., 1993) was increased after 12 h of either LPS or hypertonic
challenge (Figure 8B). Importantly, TonEBP overexpression
enhanced, and RNAi against TonEBP reduced, luciferase
activity by hypertonicity to greater extents than that
achieved by LPS. This indicates that increased NF-B activ-
ity by hypertonicity is not only dependent on binding of
TonEBP to TonE elements in target genes, if present, but also
on an interaction between TonEBP and p65 protein, as
shown in Figure 8A. ChIP and DAPA experiments show that
such an interaction occurs at B elements within minutes of
stimulation (Figure 8, C and D). Indeed, ChIP experiments
revealed that antibodies against either p65 or TonEBP were
able to immunoprecipitate DNA fragments containing B
elements located in TNF-, MCP-1, or IB promoters. Im-
munoprecipitation of these fragments increased in response
to hypertonicity. In contrast, only the anti-TonEBP antibody
immunoprecipitated DNA fragments containing a TonE se-
quence located in the AR promoter, suggesting that p65 does
not complex with TonEBP bound to TonE elements. For
DAPA experiments, we used biotinylated double-stranded
DNA fragments containing B binding sites located in
TNF- or MCP-1 promoters as bait to pull down protein
complexes bound to the DNA. Consistent with results ob-
tained from ChIP experiments, hypertonicity increased the
abundance of TonEBP bound to either DNA fragment. Al-
though the highest signal corresponding to precipitated p65
was obtained from cells challenged 30 min with LPS, that
corresponding to precipitated TonEBP was obtained from
cells challenged 30 min with hypertonic medium (Figure
8C). Collectively, data (Figure 8) show that 1) TonEBP
interacts with p65, 2) this interaction increases with envi-
Figure 5. NF-B signaling by hypertonicity
overlaps that elicited by TNF- and TGF-. (A)
Schematic illustration of NF-B activation by
LPS, TNF-, and TGF-. Binding of each li-
gand to partner receptors initiates distinct
transduction cascades that all ultimately lead
to IKK activation. Under basal states, IB
interacts with p65, retaining it in the cyto-
plasm. Once activated, IKK typically phos-
phorylates IB, leading to its degradation.
This allows nuclear translocation of liberated
p65-containing complexes, typically p65-p50
dimers. Tools used in this study to investigate
the putative roles of target molecules in hyper-
tonic NF-B inducibility are shown. Also
shown is p38 kinase whose role in NF-B ac-
tivation by hypertonicity was investigated. (B
and C) Real-time PCR analysis of TNF- tran-
script in cells challenged with hypertonic me-
dium (NaCl, 500 mOsmol/kg), TNF- (0.1–100
ng/ml), or TGF- (1–1000 ng/ml) in the ab-
sence or presence of IgG against TNF- (B) or
TGF- (C). Data are represented as fold induc-
tion over nonstimulated (Ctl) cells. (D) Real-
time PCR analysis of TNF- transcript in cells
challenged with LPS, TNF-, TGF- (100 ng/
ml), or hypertonic medium alone or simulta-
neously challenged with two stimuli. Data are
represented as fold expression over cells chal-
lenged with LPS, TNF-, or hypertonicity
alone. (E) Real-time PCR analysis of TNF-
transcript in cells transfected with scrambled
RNAi, RNAi against MyD88, or RNAi against
TNFR1 and TNFR2 or cells treated with 10 M
of the EGFR antagonist AG1478. Cells were
challenged with LPS, TNF-, TGF-, or hyper-
tonic medium. Data are represented as fold
expression over cells challenged with either
stimulus alone.
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presence of TonE sites is not mandatory for this interac-
tion, and 4) p65-TonEBP complexes bind B but not TonE
elements.
It is worth pointing out at this point observations depicted
in Figure 8 that may shed some light on the kinetics of
p65-TonEBP interactivity by hypertonicity. Both immuno-
precipitation experiments (Figure 8A) and DAPA experi-
ments using anti-p65 IgG (Figure 8D) revealed that p65 and
TonEBP interaction increased over time. Alternatively, no
time-dependent differences were observed in DAPA exper-
iments by using anti-TonEBP IgG, although a nonsigniﬁcant
increase was observed (Figure 8D). Together, these results
suggest that at early time points, the subpopulation of p65
interacting with TonEBP at B elements, as opposed to the
entire p65 pool, is too small to be readily observed by DAPA
experiments by using anti-p65 IgG. In contrast, the TonEBP
pool interacting with p65 at B elements after short periods
of challenge is large enough to produce a signal readily
visible by DAPA using anti-TonEBP IgG. After longer peri-
ods of challenge, as p65-TonEBP interactivity increases, a
sufﬁcient pool of p65 interacts with TonEBP at B elements,
allowing visualization of p65-TonEBP complexes by DAPA
using either anti-p65 or anti-TonEBP IgG. Such time-depen-
dent variations were not observed in ChIP experiments (Fig-
ure 8C). However, these subtle differences may very well be
masked by experimental variability.
Hypertonicity Induces TonEBP- and Akt-dependent NF-B
Activation in Macrophages
Cytokine production by macrophages constitutes a major
part of the inﬂammatory response. Numerous studies have
focused on determining the effects of hypertonicity on cyto-
kine production and these led to seemingly contradictory
results (Kolsen-Petersen, 2004). Recent data suggest a major
role for TonEBP in the control of extracellular volume ho-
meostasis by macrophages (Machnik et al., 2009). The results
of our present study encouraged us to perform a set of
experiments on H36.12j cells, a hybrid macrophage cell line,
to evaluate the roles of TonEBP and Akt on NF-B activation
by hypertoncity in macrophages. As revealed by increased
expression of TNF- mRNA, NF-B activity increased after
3 h of LPS (10 ng/ml) or hypertonic (400 mOsmol/kg)
challenge (Figure 9, A and C), although the stimulatory
effect produced by either stimulus was smaller than that
observed in mpkCCDcl4 cells. Similar to mpkCCDcl4 cells,
LPS did not affect AR mRNA expression (Figure 9, A and C).
RNAi against TonEBP greatly reduced TonEBP expression,
decreased its activity, as revealed by reduced levels of AR
mRNA expression, and blunted increased TNF- mRNA
expression after hypertonic challenge (Figure 9A). Reduced
TonEBP expression in macrophages decreased, but did not
abolish, TNF- mRNA expression after LPS challenge (Fig-
ure 9A). Similar to mpkCCDcl4 cells, IB protein expression
ﬁrst decreased during the ﬁrst hour of hypertonic challenge
Figure 6. p38 kinase and Akt mediate NF-B activation by hypertonicity. (A) Immunoblot of protein lysates against Akt phosphorylated
at Ser473, nonphosphorylated Akt, and phosphorylated and nonphosphorylated p38 kinase. Cells were treated or not with 100 nM
wortmannin (a PI3-kinase antagonist), 30 M triciribine (an Akt antagonist), or 10 M SB203580 (a p38 kinase antagonist) and challenged or
not (Ctl) with LPS, TNF-, TGF-, or hypertonic medium (NaCl). (B) Fold expression of phosphorylated Akt and phosphorylated p38 kinase
by either hypertonicity or TGF- in the presence or absence of a pharmacological inhibitor over that of nonstimulated (Ctl) cells. (C and D)
Real-time PCR analysis of TNF- transcript (C) or AR, BGT1 and SMIT transcripts (D) in cells challenged with hypertonic medium in the
presence or absence of wortmannin, triciribine (C) or wortmannin, triciribine or AG1478 (10 M) (D). The effects of SB203580 and triciribine,
applied alone or together, on hypertonic stimulation of TNF- expression and TonEBP activity is shown at right of each ﬁgure. Data are
represented as fold decrease of hypertonicity-induced mRNA expression by pharmacological inhibitors.
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9B). Triciribine (30 M) abolished hypertonicity-induced
IB degradation, dramatically reduced AR mRNA stimu-
lation by hypertonicity (Figure 9B) and signiﬁcantly reduced
TNF- mRNA stimulation by either LPS or hypertonicity
(Figure 9C). Together, these data show that hypertonicity
induces NF-B activity in H36.12j cells, an event that is
dependent on both TonEBP and Akt, supporting the idea
that our observations made in mpkCCDcl4 cells can be ex-
trapolated to macrophages.
DISCUSSION
In this study, we show that increased NF-B activity on the
onset of hypertonic challenge depends on increased activi-
ties of p38 kinase, Akt, and TonEBP. As depicted in Figure
10, p38 kinase enhances TonEBP activity at least in part by
stimulating Akt activity. Akt in turn increases NF-B activ-
ity by enhancing both TonEBP activity and IB degrada-
tion. IB degradation leads to increased nuclear transloca-
tion of p65-containing NF-B complexes. Although this
event alone sufﬁces to induce weak NF-B activity, it nota-
bly increases the ability of hypertonicity-activated TonEBP
to associate with p65, considerably enhancing NF-B tran-
scriptional activity.
Hypertonicity imparts massive changes on cell physiol-
ogy, many of which are part of a collective effort that allows
cells to adapt and survive in hypertonic environments. A
critical component of this prosurvival response is the ability
of the challenged cell to rapidly accumulate organic os-
molytes. This allows cytoplasmic ionic strength to return to
its original level, thereby preventing continual macromolec-
ular damage. Although a fundamental interspecies event,
the signaling mechanisms and nature of accumulated os-
molytes vary between species. In mammalian cells, the im-
portance of TonEBP in osmolyte accumulation is well ap-
preciated. The effect of hypertonicity on NF-B activity, in
contrast, is less obvious. Altered NF-B activity in response
Figure 7. Hypertonicity induces IB degra-
dation and p65 nuclear translocation indepen-
dently of TonEBP. (A) Immunoblot of protein
lysates against IB or PKAc (used as a load-
ing control) in cells challenged or not (Ctl)
with LPS, TNF-, hypertonic medium (NaCl),
or TGF- for various times. Time-dependent
IB degradation by each stimulus is repre-
sented as fold IB expression in stimulated
cells at each time point over nonstimulated
cells. (B) Real-time PCR analysis of IB tran-
script in cells pretreated 15 min with actino-
mycin D (10 M) and then challenged or not
(Ctl) with LPS, TNF-, or hypertonic medium
for various times. Data are represented as fold
IB transcript expression in stimulated cells
over that of nonstimulated cells before addi-
tion of actinomycin D. (C) Immunoblot of cy-
toplasmic and nuclear protein lysates against
TonEBP, p65, histone deacetylase 3 (HDAC3,
(used as a loading control for nuclear extracts),
and Tubulin (used as a loading control for
cytosolic extracts) in cells challenged or not
(Ctl) with LPS or hypertonic medium for 30
min. Fold TonEBP and p65 expression in cyto-
plasmic and nuclear extracts over that of non-
stimulated cells (Ctl) is shown at right. (D and
E) Immunoblot of protein lysates against IB,
PKAc (used as a loading control) (D) and
TonEBP (E) in cells pretreated or not with Akt
antagonist triciribine and then challenged or
not (Ctl) with hypertonic medium for 15 min
(D) or in cells transfected with scrambled
RNAi or TonEBP RNAi and then challenged or
not (Ctl) with hypertonic medium for 15 min
or 1 h (E). IB protein expression is repre-
sented as fold expression over control cells. (F)
Immunoblot of cytoplasmic and nuclear pro-
tein lysates against TonEBP, p65, HDAC3, and
Tubulin in cells transfected with scrambled
RNAi or TonEBP RNAi and challenged with
hypertonic medium for 30 min. Fold TonEBP
and p65 expression in cytoplasmic and nuclear
extracts over that of cells transfected with
TonEBP scrambled RNAi is shown at right.
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including skin ﬁbroblasts, monocytic cells, gastric epithelial
cells, and vascular smooth muscle cells (Andrieu et al., 1995;
Shapiro and Dinarello, 1997; Kim et al., 1999; Hattori et al.,
2000; Pingle et al., 2003). In the kidney, similar to our obser-
vations made in renal principal cells (this study; Hasler et al.,
2008), hypertonicity was shown to increase NF-B activity in
renal medullary interstitial cells (Hao et al., 2000). Increased
NF-B activity may represent a protective measure against
hypertoncity-induced apoptosis. In this setting, our results
show that TonEBP plays a dual role in protecting cells
against hypertonicity by controlling classical transcriptional
stimulation of TonEBP-inducible genes and by up-regulat-
ing NF-B transcriptional activity.
In contrast to effector mechanisms mediating organic os-
molyte accumulation, the signaling cascades mediating os-
mosensitive gene expression in mammalian cells are vague.
It is becoming increasingly clear that the hypertonic re-
sponse is a complex process involving the integration of
multiple signals and signal transduction pathways. Our
study shows that hypertonic activation of p38 kinase and
downstream activation of Akt play central roles in both
TonEBP activity and p65 nuclear translocation. Our data
further show that this leads to increased interaction between
TonEBP and NF-B, which in turn probably enhances the
osmoprotective response. What are the mechanistic implica-
tions of such an interaction? A genome-wide RNAi screen
performed on Caenorhabditis elegans demonstrated that loss
of function of genes encoding proteins that normally main-
tain levels of properly folded and functioning proteins, in-
cluding those involved in protein synthesis, folding, and
degradation, triggers an osmoprotective response (Lamitina
et al., 2006). This offers the intriguing possibility that protein
damage may function as a signal to activate osmoprotective
gene expression. In this respect, an antiapoptotic response
mediated by TonEBP-NF-B interactivity would give cells
Figure 8. TonEBP associates with p65 on the
onset of hypertonic challenge. (A) Immunoblot
against p65 and TonEBP immunoprecipitated by
anti-TonEBP or anti-p65 IgG, respectively, or unre-
lated IgG (Na,K-ATPase  subunit) in cells chal-
lenged or not (Ctl) with hypertonic medium
(NaCl) for 10 or 30 min. Also shown is the absence
of bands from lysates precipitated in the absence of
either agarose beads or IgG. Similar amounts of
p65 and TonEBP between experimental conditions
were loaded onto gels before immunoprecipitation
(Input, corresponding to 5% of immunoprecipi-
tated protein). Fold immunoprecipitated TonEBP
and p65 over that of nonstimulated cells (Ctl) is
shown at right. (B) NF-B–driven luciferase activ-
ity in response to hypertonic (NaCl) or LPS chal-
lenge. Cells were transfected with a NF-B-Luc
plasmid described in Materials and Methods and
cotransfected with cDNA encoding either eGFP or
TonEBP (left) or with scrambled RNAi or RNAi
against TonEBP (right). Data shown is represented
as fold induction over nonstimulated cells trans-
fected either with cDNA encoding eGFP or scram-
bled RNAi. (C) ChIP analysis. The localization of
B sites of mouse TNF-, MCP-1, and IB pro-
moters as well as the TonE site of mouse AR pro-
moter chosen for analysis is shown. Localization is
relative to the AUG start codon. Cells were chal-
lenged or not (Ctl) with hypertonic medium for 10
or 30 min before DNA fragmentation and immu-
noprecipitation using anti-TonEBP or p65 antibod-
ies. Immunoprecipitated DNA was analyzed by
real-time PCR using primers ﬂanking B sites of
TNF-,MCP-1,o rIBpromoters or the TonE site
of the AR promoter. Data are represented as fold
induction over nonstimulated cells. Negative con-
trols consisted of DNA fragments precipitated in
the absence of antibody or with anti- Na,K-ATPase
 subunit IgG. (D) DAPA experiments were per-
formed on nuclear extracts of cells challenged or
not (Ctl) with hypertonic medium for 10 or 30 min
or with LPS for 30 min. Precipitated protein by
DAPA probes encompassing B sites of MCP-1 or
TNF- promoters depicted in C was analyzed by
immunoblot using anti-TonEBP or anti-p65 IgG.
Equal loading was veriﬁed by immunoblot against
histone deacetylase 3 (HDAC3). Negative controls
consisted of protein precipitated in the absence of
either a DAPA probe or beads. Precipitated
TonEBP and p65 protein was quantiﬁed and is
graphically represented as fold expression over
control cells.
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tural stability, and decrease protein misfolding, thus allow-
ing them to adapt to their hypertonic environment.
Osmotic stress was recently shown to partly mimic tran-
scriptional responses to infection in C. elegans (Rohlﬁng et al.,
2010). Notably, GATA factors elt-2 and elt-3, implicated pre-
viously in infection-induced transcriptional responses, also
were found to mediate osmosensitive gene expression. Sim-
ilar to GATA factors, TonEBP plays an important role in
both osmoprotection and immunity by protecting osmoti-
cally challenged lymphoid tissue and stimulating cytokine
transcription in T cells (Lopez-Rodriguez et al., 2001; Go et
al., 2004). Because known homologues of rel-type transcrip-
tion factors are not expressed in C. elegans, this functional
Figure 9. NF-B activation by hypertonicity
in H36.12j cells depends on TonEBP and Akt
activity. (A) Left. immunoblot of protein ly-
sates from cells transfected with RNAi against
TonEBP or scrambled RNAi. The arrow de-
picts the band corresponding to TonEBP.
Right, real-time PCR analysis of AR and TNF-
transcripts in cells transfected with RNAi
against TonEBP or scrambled RNAi and ex-
posed to LPS or hypertonic medium (NaCl).
Data are represented as fold induction over
nonstimulated cells transfected with scram-
bled RNAi (Ctl). (B) Left, immunoblot of pro-
tein lysates against IB or PKAc (used as a
loading control) in cells challenged or not (Ctl)
with hypertonic medium for various periods.
Time-dependent IB degradation is graphi-
cally represented as fold IB expression in
stimulated cells at each time point over non-
stimulated cells. (B) Right, immunoblot of pro-
tein lysates against IB or PKAc (used as a
loading control) in cells pre-treated or not with
Akt antagonist triciribine and challenged or
not (Ctl) with hypertonic medium for 30 min.
IB protein expression is graphically repre-
sented as fold expression over control cells. (C)
Real-time PCR analysis of AR and TNF- tran-
scripts in cells treated or not with triciribine
and challenged with either LPS or hypertonic
medium for 3 h. Data are represented as fold
induction over nonstimulated (Ctl) cells.
Figure 10. Proposed mechanism for NF-B activation
by hypertonicity. Hypertonicity activates NF-Bi na
two-step process. In a ﬁrst step, hypertonicity stimulates
p38 kinase, which enhances the activities of both Akt
and TonEBP. Increased Akt activity in turn not only
contributes to enhancing TonEBP activity but also in-
duces IB to dissociate from cytosolic p65. This process
depends on IKK activity. Unconjugated IB is de-
graded allowing free p65, associated with other NF-B
binding partners such as p50, to translocate across the
nuclear membrane. In a second step, TonEBP associates
with p65-containing complexes bound to DNA, enhanc-
ing NF-B transcriptional activity. NF-B activation by
hypertonicity is transient and decreases as IB protein
expression increases in response to increased IB tran-
scriptional activity.
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between TonEBP and NF-B signaling shown in our study
further highlights functional interactivity between osmopro-
tective mechanisms and immunity.
Increased NF-B Activity by Hypertonicity: Role of TonEBP
Several observations made in the present study provide sound
evidence that p65-TonEBP interactivity at B elements consti-
tutes a major mechanism by which hypertonicity induces
NF-B activity. 1) Changes observed for TNF- mRNA expres-
sion were echoed not only by similar changes in MCP-1 and
IB mRNA expression (Figure 3) but also luciferase activity,
the latter of which is driven by a promoter that contains B but
not TonE elements (Figure 8B). 2) We have shown previously
that increased TNF- mRNA expression by hypertonicity is
enhanced by constitutively active IKK and reduced by both
super-repressor IB and RNAi against p65 (Hasler et al.,
2008). This same study showed that NF-B–driven luciferase
activity by hypertonicity is abolished by super-repressor IB.
Because NF-B mutants have no effect on TonEBP activity
(Figure 4), these results probably reﬂect changes in TonEBP-
p65 interactivity. 3) An interaction between TonEBP and p65 is
directly shown by immunoprecipitation, ChIP, and DAPA ex-
periments (Figure 8), the latter two experiments of which also
show binding of TonEBP-p65–containing complexes to B ele-
ments.
Hypertonicity transiently increased p38 kinase, ERK, JNK,
and Akt phosphorylation levels, but only p38 kinase and Akt
were found to control TonEBP activity. The exact role of p38
kinase in regulating TonEBP activity in mammalian cells is
subject to some debate. Although data of some studies indicate
that p38 kinase plays no role (Kwon et al., 1995; Kultz et al.,
1997), other pieces of evidence suggest that p38 kinase helps
activate TonEBP by targeting the TonEBP transactivation do-
main, although it is not clear whether this involves direct
phosphorylation of TonEBP by p38 kinase itself (Ko et al., 2002;
Kuper et al., 2009). Other signaling pathways in addition to p38
kinase regulate TonEBP activity (Burg et al., 2007; Kwon et al.,
2009; Zhou et al., 2010). Of special interest to this study, PI3-
kinase was shown previously to enhance TonEBP activity un-
der hypertonic conditions (Irarrazabal et al., 2004). This event
was found to occur independently of p38 kinase but did de-
pend on ataxia telangiectasia mutated protein kinase activation
(Irarrazabal et al., 2006), possibly by affecting TonEBP phos-
phorylation and its ensuing transactivation. EGFR signaling
was recently found to stimulate TonEBP transcriptional activ-
ity during osmotic stress, although the authors did not inves-
tigate a role played by Akt (Kuper et al., 2009). Results of the
present study (Figure 6) strongly suggest a role for Akt in
controlling TonEBP activity. They also indicate that TonEBP
activity is regulated by p38 kinase, not only via downstream
phosphorylation of Akt but also via an Akt-independent mech-
anism.
TonEBP activity varies according to environmental tonic-
ity. Although partly active under isotonic conditions, a rise
or fall of environmental tonicity enhances and reduces, re-
spectively, its activity (Kwon et al., 2009). Our data show that
although TonEBP controls NF-B activation by hypertonic-
ity, it only plays a marginal role in NF-B activation by LPS
or TNF- (Figures 3 and 8). Nuclear translocation of NF-B
complexes is increased in response to LPS, TNF-, and hy-
pertonic challenge. TonEBP activity, in contrast, is increased
only by hypertonicity, not by LPS or TNF-. These results
strongly indicate that changes of NF-B activity that follow
changes of environmental tonicity directly reﬂect TonEBP
activity levels. Our data further indicate that TonEBP does
not affect IB degradation (Figure 7) and that both in-
creased TonEBP activity and p65 nuclear translocation con-
tribute to enhancing NF-B activity on the onset of hyper-
tonic challenge. As stated, in addition to binding to TonE
elements of NF-B-sensitive genes, when present, TonEBP
exerts its effects via NF-B transactivation by binding to a
p65-containing complex at B elements (Figure 8).
The physiological importance of modulated NF-B transac-
tivation has been demonstrated by the roles of various mole-
cules that regulate NF-B transcriptional activity, such as
NF-B coactivator CBP/p300, glycogen synthase kinase-3,
and T2K (Zhong et al., 1997; Bonnard et al., 2000; Hoeﬂich et al.,
2000). Several studies have shown that activator protein (AP)-1
alters NF-B activity by physically interacting with it (Stein et
al., 1993; Thomas et al., 1997; Li et al., 2000; Xiao et al., 2004).
c-Fos and c-Jun physically interact with p65 through its Rel
homology domain (Stein et al., 1993). Although conﬂicting
reports have been made on the subject, Irarrazabal et al. (2008)
provide evidence that AP-1 enhances TonEBP-dependent gene
transcription by physically associating with it at its DNA bind-
ing site. Results of that study indicate that c-Fos and c-Jun
physically associate with a region located near amino acid 547
of TonEBP, i.e., near the Rel homology domain. Data depicted
in Figure 2C tentatively suggest competitive binding between
p65 and AP-1 for Rel homology domains. It is tempting to
speculate that hypertonic challenge facilitates either direct or
indirect binding between DNA-bound p65 and TonEBP via
dissociation of AP-1 from both p65 and TonEBP.
Increased NF-B Activity by Hypertonicity: Role of Akt
Our previous results (Hasler et al., 2008) as well as those of
the present study collectively show that the stimulatory
effect of hypertonicity on NF-B activity is mediated not
only by TonEBP but by TonEBP-independent IB degrada-
tion. Hypertonic activation of Akt was found to play a key
role in this process. Hence, under hypertonic conditions Akt
mediates both TonEBP activity and IB degradation.
Previous data have shown that HRG-1-activation of p38
kinase enhances NF-B activity by modulating IB phosphor-
ylation and p65 nuclear translocation (Tsai et al., 2003). MAPK
phosphatase 1 (MKP-1) has moreover been shown to repress
NF-B–dependent transcription (King et al., 2009). Our data
link p38 kinase to downstream Akt activation under hyper-
tonic conditions. Akt signaling has been extensively studied
and is associated with many human malignancies, reﬂecting
the involvement of Akt in numerous processes, including cell
proliferation and apoptosis (Nicholson and Anderson, 2002).
Whereas it is well established that Akt is integrated into the
activation process of NF-B, the exact mechanism by which
this is achieved varies between studies. Akt-mediated phos-
phorylation of Cot/Tp12 (a member of the MAP3K family)
after T-cell receptor stimulation has been shown to trigger IKK
activity (Kane et al., 2002). In another study, IKK activation by
platelet-derived growth factor in ﬁbroblasts was found to de-
pend on transient, PI3-kinase–dependent, association among
Akt, IKK, and IKK (Romashkova and Makarov, 1999). Sim-
ilarly, Akt was found to be necessary for IKK activation by
TNF-in embryonic kidney 293 cells, an event that depends on
intact PI3-kinase activity and that is partly mediated by an
association between Akt and IKK (Ozes et al., 1999). In addi-
tion to activating the classical pathway, Akt may directly phos-
phorylate p65, although contrasting results have been reported
(Madrid et al., 2000; Kane et al., 2002).
We have shown previously that RNAi against p65 reduce
the enhancing effect of hypertonicity on NF-B activity
(Hasler et al., 2008). We show here (Figures 1 and 7, A, C,
and D) that the effect of hypertonicity relies on elements of
the canonical NF-B pathway. Our data further show that
I. Roth et al.
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Akt activity (Figures 5, D and E, 6C, and 7D). It is worth-
while pointing out that although Akt phosphorylation by
TGF- was similar to that induced by hypertonicity the
extent of IB degradation by TGF- was greater than that
achieved by hypertonicity. Also, Akt pharmacological inhi-
bition alone decreased TNF- mRNA expression twofold
under isotonic conditions (data not shown). Nonetheless, the
effect of hypertonicity on NF-B transcriptional activity was
10-fold greater than that of TGF- further, indicating that
the effects of hypertonicity on NF-B activity do not rely on
increased Akt activity alone.
Unexpectedly, we found that IB mRNA expression was
unaffected by TGF- challenge and that its stimulation by
hypertonicity was not reduced by inhibition of either p38 ki-
nase, TGFR, PI3-kinase, or Akt (Supplemental Figures S3–S5),
clearly indicating that unlike TNF- and MCP-1 mRNA, hy-
pertonicity stimulates IB mRNA expression independently
of both p38 kinase and Akt. In contrast, a role for TonEBP in
regulating IB expression by hypertonicity is conﬁrmed in
Figures 3 and 8. Possibly, this discrepancy may reﬂect differ-
ences between regulatory components bound to TNF- and
MCP-1 promoters and those bound to the IB promoter.
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